Literature DB >> 4003315

Selective binding of nifedipine to amyloid fibrils.

M A Gertz, M Skinner, L H Connors, R H Falk, A S Cohen, R A Kyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4003315     DOI： 10.1016/0002-9149(85)90996-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  15 in total

Review 1.  Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.

Authors:  David C Seldin; John L Berk; Flora Sam; Vaishali Sanchorawala
Journal:  Heart Fail Clin       Date:  2011-05-20       Impact factor: 3.179

2.  Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management.

Authors:  Vasvi Singh; Alexander Tiemeier; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

3.  Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.

Authors:  Joel Buxbaum; Alice Alexander; James Koziol; Clement Tagoe; Ervin Fox; Dalane Kitzman
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

4.  Current therapeutic strategies in cardiac amyloidosis.

Authors:  Shailja Parikh; James A de Lemos
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-12

5.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Authors:  D R Jacobson; M Ittmann; J N Buxbaum; R Wieczorek; P D Gorevic
Journal:  Tex Heart Inst J       Date:  1997

Review 6.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease.

Authors:  Sandra Ihne; Caroline Morbach; Claudia Sommer; Andreas Geier; Stefan Knop; Stefan Störk
Journal:  Dtsch Arztebl Int       Date:  2020-03-06       Impact factor: 5.594

Review 8.  Amyloid and the Heart.

Authors:  Aaron M Wolfson; Kevin S Shah; Jignesh K Patel
Journal:  Curr Cardiol Rep       Date:  2019-12-03       Impact factor: 2.931

Review 9.  Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.

Authors:  Deepa M Gopal; Frederick L Ruberg; Omar K Siddiqi
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 10.  Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.

Authors:  Joel N Buxbaum; Frederick L Ruberg
Journal:  Genet Med       Date:  2017-01-19       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.